No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Natural extracts and ingredients business Treatt said on Thursday that Q1 revenues were in line with internal expectations and that Q2 had "started well".
Treatt said it was encouraged by a "robust pipeline and order intake". It also noted cash generation continued to be a focus and remains in line with management expectations for the full year.
In its Heritage unit, Treatt said it continued to leverage its deep knowledge and product capabilities to provide solutions against a market backdrop of continued high orange oil prices, and also said it remains focussed on growing higher margin Premium volumes, stating it was "well placed" with opportunities with both new and existing customers.
In its New Markets division, Treatt's China business continued to "progress well" ahead of the opening of its Shanghai Innovation Centre later in FY25.
As of 1020 GMT, Treatt shares were down 0.017% at 429.92p.
Reporting by Iain Gilbert at Sharecast.com
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.